Fulcrum Therapeutics Faces Genzyme Agreement Termination

TipRanks05:57

Express News | Fulcrum Therapeutics Inc - Sanofi to Terminate Collaboration and License Agreement With Fulcrum

Breakings05:33

Fulcrum Therapeutics Jumps Amid Takeover Speculation

Seeking Alpha03:02

Shares Of Fulcrum Therapeutics See Volume; Traders Circulating Co. Mentioned By M&A Blog

Benzinga02:50

Fulcrum Therapeutics (NASDAQ:FULC) Shareholders Have Endured a 77% Loss From Investing in the Stock Three Years Ago

Yahoo FinanceDec 20 01:07

Subdued Growth No Barrier To Fulcrum Therapeutics, Inc. (NASDAQ:FULC) With Shares Advancing 32%

Simply Wall StDec 15 20:23